Article info
PDFEditorial
Her2 low (but not negative): the newest biomarker on the block for gastro-oesophageal adenocarcinoma
- Correspondence to Dr Jaclyn Frances Hechtman, Pathology, Caris Life Sciences Inc, Irving, Texas, USA; jhechtman{at}carisls.com
Citation
Her2 low (but not negative): the newest biomarker on the block for gastro-oesophageal adenocarcinoma
Publication history
- Received August 6, 2023
- Accepted August 23, 2023
- First published September 7, 2023.
Online issue publication
November 17, 2023
Article Versions
- Previous version (7 September 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.